Immunosuppressants: Implications in Orthodontics

dc.creatorSantos, Rogério Lacerda dos
dc.creatorLacerda, Maria Cláudia Mesquita
dc.creatorGonçalves, Renato Torres
dc.creatorMartins, Marco Aurélio
dc.creatorSouza, Margareth Maria Gomes de
dc.date2018-11-29T15:55:50Z
dc.date2018-11-29T15:55:50Z
dc.date2012
dc.date.accessioned2023-09-26T23:02:47Z
dc.date.available2023-09-26T23:02:47Z
dc.identifierSANTOS, Rogério Lacerda dos; et al. Immunosuppressants: Implications in Orthodontics. Dental Press J. Orthod., v.17, n.2, p.55-61, 2012.
dc.identifier2176-9451
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/30340
dc.identifier2177-6709
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8886212
dc.descriptionThere are medications capable of affecting bone metabolism and the rate of tooth movement. Among these medications are the immunosuppressants, which act by repressing the action of T lymphocytes, however they can cause bone loss and consequently lead to osteoporosis. Osteoporosis is a common complication following kidney, heart, liver or lung transplantation. The immunosuppressant treatment for preventing organ rejection after transplantation, in general, includes glucocorticoids, cyclosporine, tacrolimus, and sirolimus. All these drugs can have jeopardizing effects on bone mineral homeostasis and consequently influence tooth movement. In recent years, however, the increasing use of immunosuppressants has raised questions about their effects on bone metabolism in patients undergoing orthodontic treatment.
dc.formatapplication/pdf
dc.languageeng
dc.publisherDental Press Editora
dc.rightsopen access
dc.subjectOssos
dc.subjectTécnicas de Movimentação Dentária
dc.subjectImunossupressor
dc.subjectOrtodontia
dc.subjectImmunosuppressant
dc.subjectTooth movement
dc.subjectBone
dc.subjectOrthodontics
dc.titleImmunosuppressants: Implications in Orthodontics
dc.typeArticle


Este ítem pertenece a la siguiente institución